Ninety percent of global healthcare and medical research money is spent on diseases that affect only 10 percent of the population, according to Michael Pollastri, a professor of chemistry and chemical biology who spoke at the College of Science Colloquium last Friday.
Nearly half a million children in the U.S. take antidepressants. In 2007, the Centers for Disease Control and Prevention released a warning for fluoxetine, one of the most highly prescribed psychiatric medications.
Release: Fluoxetine Increases Aggressive Behavior, Affects Brain Development Among Adolescent Hamsters
Fluoxetine was the first drug approved by the FDA for major depressive disorder (MDD) in children and adolescents, and to this date, it remains one of only two selective serotonin reuptake inhibitors (SSRIs) registered for treatment of MDD in children and adolescents, despite reports that indicate this class of drugs is associated with side effects, such as agitation, hostility and aggression.
Oyster reefs and sandy beaches have historically bordered many picturesque coastlines. But in an effort to prevent erosion, coastal developers are increasingly replacing these living shorelines with rocks and seawalls.
In the Pacific Northwest, beach grass communities often create sand dunes that mitigate coastal erosion and flooding risks stemming from rising sea levels caused by climate change.
While dyslexia is most often classified as a reading disorder, it is also well known to affect how individuals process spoken language.
Last week, Nature Magazine, Genome Research and Genome Biology published 30 papers on breakthrough research that will change the face of genetics.
Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.
Northeastern University physics Prof. Meni Wanunu has received an $825,000 award from the National Human Genome Research Institute (NHGRI)—an organization that supports the development of technologies to dramatically reduce the cost of DNA sequencing in an effort to broaden the applications of genomic information in medical research and health care.
You’re not sure why, but you don’t trust that guy. You wouldn’t give him a buck because you’re pretty sure he wouldn’t return the favor. What is it about him? Can you put your finger on it?